BIOR
Biora Therapeutics Inc
NASDAQ: BIOR · HEALTHCARE · BIOTECHNOLOGY
$0.22
+0.00% today
Updated 2026-04-30
Market cap
$994990.00
P/E ratio
0.61
P/S ratio
0.74x
EPS (TTM)
$0.36
Dividend yield
—
52W range
$0 – $0
Volume
—
WallStSmart proprietary scores
38
out of 100
Grade: D
Sell
Investment rating
5.3
Growth
C+5.0
Quality
C+3.5
Profitability
D8.3
Valuation
A—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$34.00
+15354.55%
12-Month target
$0.22
+0.00%
Intrinsic (DCF)
$0.82
Margin of safety
+73.17%
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 15,800.00% QoQ
+ 73.17% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-8.75M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2020 | 2021 | 2022 | 2023 | TTM |
|---|---|---|---|---|---|
| Revenue | $74.31M | $1.25M | $305000.00 | $4000.00 | $860000.00 |
| Net income | $-192.53M | $-178.52M | $-38.16M | $-124.11M | $-18.40M |
| EPS | — | — | — | — | $0.36 |
| Free cash flow | $-170.69M | $-168.34M | $-65.21M | $-48.60M | $-8.75M |
| Profit margin | -259.08% | -14,316.04% | -12,510.49% | -3,102,875.00% | — |
Peer comparison
Smart narrative
Biora Therapeutics Inc trades at $0.22. representing a P/E of 0.61x trailing earnings. Our Smart Value Score of 38/100 indicates the stock is weak. TTM revenue stands at $860000.00. Our DCF model estimates intrinsic value at $0.82.
Frequently asked questions
What is Biora Therapeutics Inc's stock price?
Biora Therapeutics Inc (BIOR) trades at $0.22.
Is Biora Therapeutics Inc overvalued?
Smart Value Score 38/100 (Grade D, Sell). DCF value $0.82.
What is the price target of Biora Therapeutics Inc (BIOR)?
The analyst target price is $34.00, representing +15354.5% upside from the current price of $0.22.
What is the intrinsic value of Biora Therapeutics Inc (BIOR)?
Based on our DCF model, intrinsic value is $0.82, a +73.2% margin of safety versus $0.22.
What is Biora Therapeutics Inc's revenue?
TTM revenue is $860000.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.74x
ROE—
Beta1.28
50D MA$0.22
200D MA$0.22
Shares out0.00B
Float0.00B
Short ratio—
Avg volume—
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—